Posts Tagged ‘ Perigee ’

Endo Offers $830 Million to Settle 20K AMS Pelvic Mesh Lawsuits

Apr 30th, 2014 | By
Endo Offers $830 Million to Settle 20K AMS Pelvic Mesh Lawsuits

*This Just In* Late this afternoon, Endo Health Solutions announced it had reached an agreement with several law firms to settle in principle about 20,000 defective pelvic mesh lawsuits sold by its subsidiary American Medical Systems. Here is Endo’s news release. That would amount to an average of $40,000 per case before legal fees are
[continue reading...]



Endo/ American Medical Systems Under Investigation for Transvaginal Mesh

Mar 5th, 2014 | By
Endo/ American Medical Systems Under Investigation for Transvaginal Mesh

Endo Health Solutions took over American Medical Systems (AMS) in 2011 for $2.9 billion and in doing do inherited roughly 22,000 transvaginal mesh lawsuits. That may have been a mistake. In its annual report released by the Securities and Exchange Commission Monday, Endo says it has received subpoenas from several states investigating its pelvic mesh
[continue reading...]



MND Interviews Dr. Veronikis: On Transvaginal Mesh, Injuries and Explants

Dec 19th, 2013 | By
MND Interviews Dr. Veronikis: On Transvaginal Mesh, Injuries and Explants

The name of Dr. Dionysios Veronikis St. Louis is one that is increasingly heard among mesh-injured women.  Dr. Veronikis tells Mesh News Desk (MND) he now spends half of his time doing mesh removal surgeries, also known as explants, and although he still uses synthetic mesh on rare occasions, his surgical skills allow him to
[continue reading...]



FDA Approves New American Medical System Transvaginal Mesh Sling

Dec 9th, 2013 | By
FDA Approves New American Medical System Transvaginal Mesh Sling

American Medical Systems (AMS) has just received FDA clearance to market a new incontinence sling, according to a press release that appears in the Wall Street Journal. The RetroArc Retropubic Sling System received the Food the Drug Administration’s 510(k) clearance, a standard that does not require any clinical trials but relies on naming a similar 
[continue reading...]



AMS Granted Limited Discovery into Alleged “Scheme” in Transvaginal Mesh Litigation

Oct 13th, 2013 | By
AMS Granted Limited Discovery into Alleged “Scheme” in Transvaginal Mesh Litigation

On Friday, October 11, AMS, American Medical Systems, was given a limited green light to look into what it alleges could be a fraudulent “scheme” to  stack the deck in the plaintiff’s favor in the ongoing transvaginal mesh litigation. At the same time, those alleged in the questionable activities were granted protection from an overbroad
[continue reading...]



Breaking News! Endo Settles Some AMS Vaginal Mesh Cases for $55 Million

Jun 21st, 2013 | By
Breaking News! Endo Settles Some AMS Vaginal Mesh Cases for $55 Million

June 21, 2013 ~ Endo Health Solutions Inc. unit has agreed to pay $54.5 million to settle some product liability lawsuits filed by women who were implanted with the Perigee, Apogee and Elevate transvaginal mesh. The women claim they were injured by the polypropylene mesh implants and call the transvaginal mesh a defective product. The
[continue reading...]



Family Tree of Meshes from The Female Patient, April 2009

May 28th, 2012 | By
Family Tree of Meshes from The Female Patient, April 2009

If you find it difficult to understand all of the different types of synthetic transvaginal mesh, this graphic from The Female Patient, April 2009 may help. Share this:



American Medical Systems Files its Position Statement Laying Out its Strategy in Court in Defective Mesh Lawsuits

Apr 9th, 2012 | By
American Medical Systems Files its Position Statement Laying Out its Strategy in Court in Defective Mesh Lawsuits

April 9, 2012 ~ On Friday, April 6, American Medical Systems Inc. (AMS) of Minnetonka, Minnesota filed its Position Statement with federal court in the Southern District of West Virginia laying out its strategy in its defense of its synthetic surgical mesh used to treat female conditions of pelvic organ prolapse (POP) and stress urinary
[continue reading...]



We hope you find this a helpful resource. National News Editor, Jane Akre, began MDND with the hope of providing the latest news, information and perspective from the regulatory, industry and patient point of view, something that goes under-reported in much of the coverage of medical devices. The public is just now becoming aware that many devices do not undergo the same scrutiny as prescription drugs and are instead grandfathered in under an FDA loophole that has gone largely unchanged since the 1970s. As a result, patients become the post-market clinical trial subjects, and many suffer devastating and permanent injuries.